Drug profile · INN
mitoxantrone hydrochloride
MITOXANTRONE HYDROCHLORIDE
mitoxantrone hydrochloride (MITOXANTRONE HYDROCHLORIDE) is a dna topoisomerase ii alpha inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — mitoxantrone hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 12
- Data quality
- 0.84
Quick answer
mitoxantrone hydrochloride (MITOXANTRONE HYDROCHLORIDE) is a dna topoisomerase ii alpha inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA topoisomerase II alpha inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mitoxantrone hydrochloride?
mitoxantrone hydrochloride (MITOXANTRONE HYDROCHLORIDE) is a dna topoisomerase ii alpha inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for mitoxantrone hydrochloride?
MITOXANTRONE HYDROCHLORIDE is a marketed brand name for mitoxantrone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mitoxantrone hydrochloride?
mitoxantrone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.